Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
09/2004
09/01/2004EP1451158A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
09/01/2004EP1451157A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
09/01/2004EP1451153A1 Nk1 antagonists
09/01/2004EP0827499B1 Process for producing 5,6-dihydro-1,3-oxazines
09/01/2004CN1525957A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
09/01/2004CN1524960A Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
09/01/2004CN1164573C Novel alpha-amino acid compound, its preparation process and medicinal composition containing same
08/2004
08/31/2004US6784323 Enantioselective transformation of α,β-unsaturated aldehydes using chiral organic catalysts
08/31/2004US6784197 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
08/31/2004US6784193 Mutilin derivatives and their use as antibacterials
08/31/2004US6784182 Serine protease inhibitors
08/31/2004US6784173 Aromatic dicarboxylic acid derivatives
08/31/2004US6784167 17-beta-hydroxysteroid dehydrogenase-II inhibitors
08/26/2004WO2004072025A2 Substituted n-arylheterocycles, method for production and use thereof as medicaments
08/26/2004WO2004071460A2 Cyclic derivatives as modulators of chemokine receptor activity
08/26/2004WO2004071449A2 Lactams as modulators of chemokine receptor activity
08/26/2004WO2004071445A2 2-(aminomethyl)arylamide analgesics
08/26/2004WO2004071382A2 Substituted heterocycles
08/26/2004WO2004050610A3 Modulators of melanocortin receptor
08/26/2004WO2004013094A3 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
08/26/2004US20040167358 Method and reagents for N-alkylating ureides
08/26/2004US20040167341 Pyrrolidines as dipeptidyl peptidase inhibitors
08/26/2004US20040167332 Boronic ester and acid compounds, synthesis and uses
08/26/2004US20040167201 Pyrrolidine melanocortin-specific compounds
08/26/2004US20040167191 Glutaminyl based DPIV inhibitors
08/26/2004US20040167183 Protein tyrosine phosphatase inhibitor; antidiabetic agents; hypotensive agents; cardiovascular disorders; inflammatory bowel disorders; antiulcer agents; wound healing agents; anticancer agents
08/26/2004US20040167131 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
08/26/2004US20040167129 Novel CB 1 receptor inverse agonists
08/26/2004US20040167126 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors
08/26/2004US20040167124 Viricides; immunology moderator
08/26/2004US20040167119 2-(aminomethyl) arylamide analgesics
08/26/2004US20040167116 Viricides
08/26/2004US20040167040 quaternary ammoniumalkyl- derivatives (especially betaines) of succinimides prepared from succinic anhydrides and di-substituted aminoalkylamines; for use in equipment for extracting and transporting hydrocarbons in crude oil extraction and processing.
08/26/2004US20040167031 Arylphenyl-substituted cyclic ketoenols
08/26/2004DE10305089A1 Neue heteroarylsubstituierte Acetonderivate als Hemmstoffe der Phospholiphase A2 New heteroaryl substituted acetone derivatives as inhibitors of phospholipase A2
08/26/2004CA2516118A1 Substituted n-arylheterocycles, method for production and use thereof as medicaments
08/25/2004EP1449830A1 Preparation of lactams from aliphatic - dinitriles
08/25/2004EP1448539A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/25/2004EP1448534A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition ofthe coagulation cascade
08/25/2004EP1448523A1 Heterocyclic compounds and methods of use
08/25/2004EP1448522A1 Gabusectin derivatives, method for the production thereof and use of the same
08/25/2004EP1448521A1 Derivatives of andrimide and moiramide b having antibacterial properties
08/25/2004EP1448520A1 Benzamide derivatives, processes for their preparation, and their pharmaceutical use
08/25/2004EP1448519A1 Method for the continuous production of n-methyl-2-pyrrolidone (nmp)
08/25/2004EP1448516A1 Hydroxyethylene compounds with asp2 inhibitory activity
08/25/2004EP1448218A2 Beta-secretase inhibitors and methods of use
08/25/2004EP1448180A1 Para-amino benzoic acids as integrin antagonists
08/25/2004EP1278728B1 Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders
08/25/2004EP1200457B1 Cysteine protease inhibitors
08/25/2004EP1149069B1 Phenylglycine derivatives
08/25/2004EP0942068B1 Process for the preparation of optically active n-benzyl-3-pyrrolidinol
08/25/2004CN1524073A Crystalline forms of 'r-(r*,r*)-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-'phenylamino)carbonyl!-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin)
08/25/2004CN1524072A Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
08/25/2004CN1522701A Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy
08/25/2004CN1163477C Substituted beta-alanine
08/24/2004US6780998 Substituted 2-aminoalkyl-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same
08/24/2004US6780950 Pyrrole compounds, polymers thereof and EL element using the same
08/24/2004US6780858 Hydroxyamidines and related compounds
08/24/2004US6780857 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
08/19/2004WO2004070352A2 Methods, mixtures, kits and compositions pertaining to analyte determination
08/19/2004WO2004069841A1 3-phenyl substituted 3-substituted-4-ketolactams and ketolactones
08/19/2004WO2004069805A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
08/19/2004WO2004069797A1 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2
08/19/2004WO2004069796A2 Process for producing levetiracetam
08/19/2004WO2004069793A2 Novel 2-substituted cyclic amines as calcium sensing receptor modulators
08/19/2004WO2004069782A2 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
08/19/2004WO2004069394A2 Synthetic method for direct arylation of heterocyclic arenes
08/19/2004WO2004069227A1 Aqueous dispersion comprising stable nanoparticles of a water-insoluble pyrrole carboxamide and excipient like middle chain triglycerides
08/19/2004WO2004058705A3 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor
08/19/2004WO2004054973A3 Piperidine and pyrrolidine derivatives as antagonists of histamine h3 receptor
08/19/2004WO2004037784A3 Pyrrolidones with anti-hiv activity
08/19/2004WO2003053918A3 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof
08/19/2004WO2003038123A3 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
08/19/2004US20040162435 Novel aliphatic compound, method of synthesis, and method of utilization
08/19/2004US20040162331 Heterocylic amines used as antidiabetic or hyperglycemic agents
08/19/2004US20040162329 Structural carotenoid analogs for the inhibition and amelioration of disease
08/19/2004US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/19/2004US20040162281 Pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents
08/19/2004DE20306257U1 Bearbeitungsvorrichtung Processing apparatus
08/19/2004CA2515235A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
08/19/2004CA2515147A1 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2
08/19/2004CA2515090A1 Process for producing levetiracetam
08/19/2004CA2513531A1 3-phenyl substituted 3-substituted-4-ketolactams and ketolactones
08/18/2004EP1447399A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses"
08/18/2004EP1447398A1 Retroviral protease inhibitors
08/18/2004EP1446665A2 Isotopically coded affinity markers 3
08/18/2004EP1446496A2 Methods for ligand dicovery
08/18/2004EP1446116A1 Inhibitors of dipeptidyl peptidase iv
08/18/2004EP1087935B1 Anthracene derivatives as anti-cancer agents
08/18/2004CN1522244A Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
08/18/2004CN1521155A Functional additive having UV-absorbing substituent and ink composition containing the same
08/18/2004CN1162403C Substituted amino benzonitrile
08/18/2004CN1162400C Process for synthesizing long chain active ester with end functional group
08/18/2004CN1162397C Therapeutically and/or nutritionaly enhanced derivatives of active ingredients and orally administrable compsns. contg. the same
08/18/2004CN1162151C Patassium channel activators
08/17/2004US6777560 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
08/17/2004US6777552 From an ester derivative or protected ester derivative of the statin by using calcium hydroxide
08/17/2004US6777526 Optically active maleimide derivatives, optically active polymaleimide derivatives, production method thereof, separating agent using the same derivative, and method for separating optically active compounds using the same agent
08/17/2004US6777438 Inhibitors of farnesyl protein transferase
08/17/2004US6777425 Which binds nucleic acids/dna; gene expression; genetic engineering